Effect of Rosuvastatin on Cytokines After Traumatic Brain Injury
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether rosuvastatin could alter the immunological
response after head injury by modulating TNF-alpha,IL6,IL-1.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Universidad Autonoma de San Luis PotosÃ
Collaborators:
AstraZeneca Hospital Central "Dr. Ignacio Morones Prieto"